We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

GLBS:NASDAQGlobus Maritime Limited Analysis

Data as of 2026-06-18 - not real-time

$2.75

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Globus Maritime (GLBS) is trading at $2.75, comfortably above its 20‑day ($2.22), 50‑day ($2.14) and 200‑day ($1.67) simple moving averages, confirming a strong bullish trend. The technical picture is reinforced by a bullish MACD crossover (line 0.148 vs signal 0.081) and an accelerating volume profile, though the RSI at 74 signals the stock is approaching overbought territory and sits just below the recent resistance of $2.78. Volatility is elevated at 64% over the past 30 days and beta exceeds 1.0, indicating heightened sensitivity to market swings.
Fundamentally, GLBS posted a 42% revenue surge to $47.8 M with a solid 50% gross margin, yet profitability remains marginal (1.7% net margin) and earnings are negative (trailing EPS ‑$0.08). The balance sheet is leveraged, featuring $108 M of debt versus $27.6 M of cash, and free cash flow is negative. Despite these challenges, the discounted cash‑flow model suggests a fair value of $14.15, implying an upside of roughly 80% relative to the current price, and the market sentiment index is in “Extreme Greed” territory, supporting a short‑term price lift.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • RSI near overbought levels
  • Price approaching short‑term resistance at $2.78
  • High 30‑day volatility

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Substantial DCF upside (~80%)
  • Strong revenue growth (42%) and healthy gross margin
  • Low price‑to‑book (0.34) indicating asset value discount

Long Term

> 3 years
Positive
Model confidence: 6/10

Key Factors

  • Growing dry‑bulk fleet capacity and demand fundamentals
  • Potential for balance‑sheet improvement as cash generation stabilizes
  • Cyclical nature of marine shipping offering multi‑year recovery upside

Key Metrics & Analysis

Financial Health

Revenue Growth42.10%
Profit Margin1.72%
P/E Ratio-68.8
ROE0.47%
ROA1.31%
Debt/Equity61.16
P/B Ratio0.3
Op. Cash Flow$15.3M
Free Cash Flow$-13708500
Industry P/E31.4

Technical Analysis

TrendBullish
RSI74.5
Support$1.99
Resistance$2.78
MA 20$2.22
MA 50$2.14
MA 200$1.67
MACDBullish
VolumeIncreasing
Fear & Greed Index92.14

Valuation

Fair Value$14.15
Target Price$5.00
Upside/Downside81.82%
GradeUndervalued
TypeBlend

Risk Assessment

Beta1.04
Volatility64.40%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.